Life Science Deliveries Stall in 1Q, Pipeline Still Significant
After a record year of Life Science construction in 2024, early 2025 brings a much needed stall in new project deliveries. In 2024, 22.8 million square feet of Life Science …
After a record year of Life Science construction in 2024, early 2025 brings a much needed stall in new project deliveries. In 2024, 22.8 million square feet of Life Science …
Despite declining occupancy in 2024, it was a largely positive year on the demand side. 70% of the top 20 markets had positive absorption in 2024. Boston gained about 3.7 million in occupied space throughout . . .
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …
How much has the life science real estate sector grown over the past decade? In the table below we are looking at growth from 2014-2024 for life science inventory & employment. The inventory growth is for all . . .
The Life Science real estate sector is closing out 2024 with a total of 21.2M square feet of project completions, pushing sector inventory over 400M square feet. This represents an …
To answer this question, we are going to break up the data into two categories, the top 3 markets (Boston, San Francisco, San Diego) and the rest of the US. We are showing the square footage of construction projects that are in progress, the amount of that construction that is still available to be leased (SF Vacant in Progress) and the vacancy percentage based on those numbers. The top 3 markets had a construction vacancy of . . .
The spotlight continues to be on the Life Science real estate sector as the industry works to absorb the significant amount of new inventory coming online. Nationwide, 23 million square …
Revista tracks life science properties across the entire U.S. and virtually every area has felt an impact from reduced space demand combined with overbuilding. That being said, not every life …
While activity among the real estate side of life science is going through a slow period, it is important to zoom out and examine the outlook of the sector in the long term. How is the need for lab space going to evolve over the next 10 years? One way to analyze the space needs is to observe the trend in employment. The chart below contains data from . . .
Over the past couple of years, life science real estate occupancy has been on the decline in the top markets. The top 3 markets represent over 1/3 of the US inventory and have the longest history as biotech clusters. Prior to 2022, there was generally a nice balance between . . .
The Research Triangle has long been established as a strong biotech market, referred to as such due to the dense research and technology presence in the triangle created by UNC, …
Revista recently hosted a webcast discussing the latest data and insights for the Life Science Real Estate industry as of 1Q24. Hilda Martin and Stephen Lindsey reviewed details on supply/demand, …
Outside of the core three clusters – Boston, San Francisco and San Diego – what are the largest markets? How are they holding up with all the new recent supply …
Construction starts slowed in 2023 as funding levels came down and demand for Life Science space softened, but 2024 has begun with almost a complete halt in new construction activity. …
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
It is no secret that inventory has been increasing lately in many life science real estate markets. Developers have been responding to increasing demand for new space during the past years, especially coming out of the COVID-19 pandemic era
Many metros are struggling this year to absorb new Life Science inventory as funding has significantly scaled back and companies become more cautious on space needs. After struggling to absorb …
Boston is the center of the US Life Science universe, and it has been even more of a focal point for the investment community in the past few years. Not …